NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.
Mã chứng khoánNEO
Tên công tyNeogenomics Inc
Ngày IPODec 10, 2012
Giám đốc điều hànhMr. Antony P. Zook
Số lượng nhân viên2200
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhDec 10
Địa chỉ9490 Neogenomics Way
Thành phốFORT MYERS
Sàn giao dịch chứng khoánNASDAQ Capital Market Consolidated
Quốc giaUnited States of America
Mã bưu điện33912
Điện thoại12397680600
Trang webhttps://neogenomics.com/
Mã chứng khoánNEO
Ngày IPODec 10, 2012
Giám đốc điều hànhMr. Antony P. Zook
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu